Summary & Overview
CPT 90675: Rabies Vaccine, Intramuscular
CPT code 90675 denotes an intramuscular rabies vaccine product used to actively immunize individuals against rabies, a fatal viral disease transmitted by animal exposures. Nationally, rabies vaccination is a critical preventive service for persons with potential or confirmed rabies exposures and for certain pre‑exposure risk groups, making accurate coding essential for clinical tracking and payer reimbursement.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the vaccine, typical service settings, and common billing considerations. The publication outlines benchmarks and payer coverage patterns, highlights relevant policy updates affecting vaccine coverage and billing practices, and situates CPT code 90675 within clinical workflows for both pre‑exposure and post‑exposure contexts.
The content provides practical context for health system administrators, billing professionals, and clinicians who manage vaccine delivery and claims submission. Data not available in the input is noted where applicable. The goal is to clarify the clinical role of CPT code 90675, summarize payer coverage landscape, and identify areas where policy or documentation attention may affect claim outcomes.
Billing Code Overview
CPT code 90675 represents a rabies vaccine product administered intramuscularly to prevent rabies, a life‑threatening viral infection transmitted by the bite or scratch of an infected animal. This vaccine is used for active immunization to induce protective immunity against rabies.
Service Type: Vaccine administration (preventive/therapeutic immunization)
Typical Site of Service: Outpatient clinics, physician offices, public health clinics, emergency departments, and other ambulatory care settings where intramuscular vaccines are delivered.
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient presents to an outpatient travel clinic and emergency department after sustaining a potential rabies exposure from a dog bite while traveling. The clinical workflow begins with triage and wound assessment, documentation of the exposure event and animal status, and tetanus immunization review. A decision is made to administer rabies vaccine intramuscularly to initiate or continue post-exposure prophylaxis (PEP). The vaccine product described by 90675 is given via intramuscular injection (typically deltoid for adults, anterolateral thigh for young children). The clinician documents consent, vaccine lot number, expiration date, site and route of administration, and any concurrent immunoglobulin administration if indicated. Billing uses the vaccine product code 90675 for the vaccine itself; separate administration and evaluation codes may be reported according to payer rules. Typical site of service includes outpatient clinics, urgent care centers, emergency departments, and public health immunization clinics. Typical patient scenario: unvaccinated or previously vaccinated person with a documented bite or high-risk exposure receives a series of rabies vaccines with appropriate scheduling and documentation for follow-up doses.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |